Warning Signs and Look-Alikes
At a Glance
A conjunctival nevus is usually a stable, painless eye spot, but rapid growth, mixed colors, new blood vessels, a lump, corneal spread, bleeding, or unusual symptoms should be assessed by an eye specialist; sudden vision changes or severe pain need same-day care.
For most people, a conjunctival nevus is a stable lesion that causes no symptoms [1]. However, because several different conditions can cause spots on the eye, it is important to know which signs require an urgent trip to the doctor, which require prompt specialist evaluation, and which are common look-alikes.
Urgent Care Triggers
A typical conjunctival nevus is stable and painless. If you experience any of the following symptoms, do not assume it is just an eye freckle. Seek urgent, same-day medical care:
- Sudden vision change or vision loss
- Severe eye pain
- Marked inflammation, rapid swelling, or discharge
- Significant bleeding from the eye
These symptoms are not typical of a benign nevus and could indicate a more acute eye problem, such as an infection or an inflamed cyst, which requires immediate attention [2].
When to Seek Prompt Evaluation
While a stable nevus is not an emergency, certain changes are “red flags” that should prompt a timely appointment with an eye specialist or ocular oncologist. These signs do not always mean cancer, but they do mean the spot needs a professional look [3][4]:
- Rapid Change: Noticeable growth in size or thickness over a period of months [3].
- Color Shifts: A change from a uniform brown to a “variegated” appearance—meaning it now has multiple colors like black, gray, or red [5][6].
- New Blood Vessels: The development of prominent “feeder vessels” or intrinsic tumor vasculature around the spot [7].
- Corneal Involvement: The spot appears to be “climbing” onto the cornea (the clear window over the iris) [8][9].
- Nodularity: The spot, which used to be flat or slightly raised, has developed a distinct lump or “nodule” [4].
- Location: Spots found on the underside of the eyelid (tarsal conjunctiva) or in the deep folds of the eye (fornix) are monitored more strictly than those on the white of the eye [10].
Note: You cannot reliably assess features like clear cysts, feeder vessels, or the “mobility” of the lesion in a bathroom mirror. Do not try to rub or manipulate your eye to test if a spot moves. These are clinical signs your doctor will evaluate with a microscope.
Common “Look-Alikes”
Several other conditions can look like a simple nevus. Your doctor uses specialized tools to tell them apart.
Primary Acquired Melanosis (PAM)
PAM is a flat, patchy pigmentation that usually appears in middle-aged or older adults [11]. Unlike a nevus, which is a defined “clump” of cells, PAM often looks like a “dusting” of pigment over a larger area [12]. The main challenge with PAM is that its appearance doesn’t always tell the whole story; some cases are harmless, while others (called “PAM with atypia”) have a higher risk of turning into melanoma and require a biopsy [13][12].
Ocular Surface Squamous Neoplasia (OSSN)
OSSN is a type of surface growth that can sometimes be pigmented, making it look like a nevus [14]. However, OSSN often has a “gelatinous” or “fleshy” texture and may have a white, flaky covering called leukoplakia [15]. Doctors often use Anterior-Segment OCT (a type of high-resolution imaging) to help tell the difference: OSSN typically shows a very thick, bright surface layer, whereas a nevus usually shows clear, internal bubbles called cysts [16][17].
Conjunctival Melanoma
This is a rare but serious cancer. It can arise on its own, from PAM, or very rarely from a pre-existing nevus [3]. Warning signs include increased thickness, bleeding (hemorrhage) around the lesion, and the spot being “fixed” or stuck to the eye rather than sliding easily over the surface [10][18].
Observation Guidelines
Any new pigmented spot on your eye requires a baseline clinical examination to confirm its identity. However, if your doctor has examined the spot, taken baseline photos, and confirmed it lacks red flags, it is generally safe to follow their personalized observation schedule. A stable appearance over time and the presence of small, clear bubbles (identified by your doctor) are very reassuring signs, though they do not replace the need for professional monitoring [1][16].
Common questions in this guide
What changes in a conjunctival nevus should be checked by an eye specialist?
Which symptoms from an eye spot require same-day medical care?
How do doctors distinguish a conjunctival nevus from other pigmented eye lesions?
Is a stable conjunctival nevus usually dangerous?
Can I check a conjunctival nevus for cysts or movement at home?
Questions For You
Answer a question to get research tailored to you. Your answers are private.
Get notified when new evidence is published on conjunctival nevus.
We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.
Questions to Ask Your Doctor
Curated prompts to bring to your next appointment.
- 1.Based on my exam, does this lesion have intralesional cysts or signs of epithelial thickening?
- 2.Are there 'feeder vessels' or intrinsic blood supplies within the spot that concern you?
- 3.Is the spot mobile over the white of my eye when you examine it, or does it seem fixed to the deeper tissues?
- 4.How does the location of this spot (e.g., bulbar vs. tarsal) influence your level of concern?
- 5.If this might be Primary Acquired Melanosis (PAM), how will we determine if it has atypia?
References
References (18)
- 1
Conjunctival Nevus.
Huang JJ, Locatelli EVT, Chocron A, et al.
Current ophthalmology reports 2023; (11(4)):104-112 doi:10.1007/s40135-023-00315-w.
PMID: 38390435 - 2
Infected Inclusion Cyst of a Conjunctival Nevus Treated with a Mini-Incision: A Case Report.
Blavakis E, Kecik M, Thumann G, Massa H
Case reports in ophthalmology 2024; (15(1)):585-589 doi:10.1159/000539846.
PMID: 39144646 - 3
Conversion of Conjunctival Nevus to Melanoma in a Patient Taking the TYK2 Inhibitor Deucravacitinib.
Whitcomb N, Lee HJ
Cornea 2026; (45(1)):105-107 doi:10.1097/ICO.0000000000003942.
PMID: 40742181 - 4
Spectrum of conjunctival tumours in a Spanish series: A review of 462 cases.
García Onrubia L, Pacheco-Callirgos GE, Portero-Benito A, et al.
European journal of ophthalmology 2020; (30(6)):1403-1409 doi:10.1177/1120672119870736.
PMID: 31436111 - 5
Diagnostic Algorithm for Conjunctival Melanocytic Lesions.
Dębicka-Kumela M, Romanowska-Dixon B, Karska-Basta I, et al.
Anticancer research 2021; (41(6)):3161-3167 doi:10.21873/anticanres.15102.
PMID: 34083311 - 6
The Evaluation of the Malignant Characteristics of Conjunctival Lesions Based on the Dermatoscopic Algorithm.
DĘbicka-Kumela M, Romanowska-Dixon B, Karska-Basta I, et al.
Anticancer research 2021; (41(2)):895-903 doi:10.21873/anticanres.14842.
PMID: 33517295 - 7
Indocyanine Green Angiographic Assessment of Conjunctival Melanocytic Disorders.
Palme C, Wanner A, Romano V, et al.
Cornea 2021; (40(12)):1519-1524 doi:10.1097/ICO.0000000000002681.
PMID: 33591034 - 8
High-Resolution Anterior Segment Optical Coherence Tomography Characteristics of Conjunctival Tumors.
Ocaktan O, Horozoglu F, Sener H, Özer F
Journal of clinical practice and research 2026; (48(2)):153-161 doi:10.14744/cpr.2026.14313.
PMID: 42305277 - 9
Invasive conjunctival melanoma mimicking ocular surface squamous neoplasia: a case series.
Gallo B, Thaung C, Hay G, et al.
The British journal of ophthalmology 2021; (105(6)):775-778 doi:10.1136/bjophthalmol-2019-315393.
PMID: 32675060 - 10
Conjunctival Tumors in 5002 Cases. Comparative Analysis of Benign Versus Malignant Counterparts. The 2016 James D. Allen Lecture.
Shields CL, Alset AE, Boal NS, et al.
American journal of ophthalmology 2017; (173()):106-133 doi:10.1016/j.ajo.2016.09.034.
PMID: 27725148 - 11
Differential diagnosis and management of melanocytic lesions of the ocular surface
Tóth G, Szalai E, Csákány B, et al.
Orvosi hetilap 2020; (161(15)):563-574 doi:10.1556/650.2020.31699.
PMID: 32320191 - 12
Conjunctival Melanocytic Lesions.
Bresler SC, Simon C, Shields CL, et al.
Archives of pathology & laboratory medicine 2022; (146(5)):632-646 doi:10.5858/arpa.2021-0006-RA.
PMID: 34424954 - 13
Conjunctival Primary Acquired Melanosis: Is It Time for a New Terminology?
Jakobiec FA
American journal of ophthalmology 2016; (162()):3-19.e1.
PMID: 26556007 - 14
A Case of Conjunctival Melanoma Presenting as a Squamous Cell Carcinoma.
Menna F, Tschopp M, Meyer P, Papazoglou A
Case reports in ophthalmology 2024; (15(1)):742-750 doi:10.1159/000541860.
PMID: 39464315 - 15
Clinical Presentation of Ocular Surface Squamous Neoplasia in Kenya.
Gichuhi S, Macharia E, Kabiru J, et al.
JAMA ophthalmology 2015; (133(11)):1305-13 doi:10.1001/jamaophthalmol.2015.3335.
PMID: 26378395 - 16
Anterior Segment Swept-Source Optical Coherence Tomography in Ocular Surface Tumors and Simulating Lesions and Correlation With Histopathologic Diagnosis.
Gündüz AK, Mirzayev I, Ersöz CC, et al.
Cornea 2025; (44(7)):806-818 doi:10.1097/ICO.0000000000003856.
PMID: 40152549 - 17
Anterior segment optical coherence tomography in ocular surface tumours and simulating lesions.
Gündüz AK, Mirzayev I, Okcu Heper A, et al.
Eye (London, England) 2023; (37(5)):925-937 doi:10.1038/s41433-022-02339-1.
PMID: 36513855 - 18
Clinical Features Differentiating Benign From Malignant Conjunctival Tumors in Children.
Shields CL, Sioufi K, Alset AE, et al.
JAMA ophthalmology 2017; (135(3)):215-224 doi:10.1001/jamaophthalmol.2016.5544.
PMID: 28125759
This page is for informational purposes only and does not constitute medical advice or diagnose an eye lesion. An ophthalmologist should assess any new or changing conjunctival spot, and urgent symptoms need same-day care.